T-group (topology)
102.1.3 PAP/OAS1 substrate-binding domain
Ligands and drugs
1,457
Member domains
531
with ligand contacts (≤ 4 Å)
36.4% of members
373
with DrugDomain annotations
25.6% of members
240
with a DrugBank compound
16.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 102.1.3 belongs to X-group 102 HhH/H2TH, which binds 6.9 ligand superclasses per 20 proteins, narrower than 61% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 41 |
| DB04005 | UTP | Uridine 5'-triphosphate | 35 |
| DB02431 | CTP | Cytidine-5'-Triphosphate | 32 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 19 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 15 |
| DB16833 | ADP | Adenosine disphosphate | 13 |
| DB01860 | 3AT | Cordycepin Triphosphate | 9 |
| DB00131 | AMP | Adenosine phosphate | 7 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 5 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 5 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 4 |
| DB03685 | U5P | Uridine monophosphate | 3 |
| DB01190 | CLY | Clindamycin | 2 |
| DB01694 | TAR | D-tartaric acid | 2 |
| DB02333 | DUT | Deoxyuridine-5'-Triphosphate | 2 |
| DB03532 | G2P | Phosphomethylphosphonic acid guanylate ester | 2 |
| DB04160 | PPV | Pyrophosphoric acid | 2 |
| DB02153 | — | — | 1 |
| DB02189 | DDS | 2',3'-Dideoxyadenosine triphosphate | 1 |
| DB02987 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 252 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 79 |
| UTP | URIDINE 5'-TRIPHOSPHATE | 37 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 33 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 23 |
| CL | CHLORIDE ION | 21 |
| MGmetal | MAGNESIUM ION | 18 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 15 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 13 |
| 1SY | cGAMP | 12 |
| 3AT | 3'-DEOXYADENOSINE-5'-TRIPHOSPHATE | 11 |
| 2KH | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]amino}phosphoryl]uridine | 10 |
| IOD | IODIDE ION | 9 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 5 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 5 |
| OKR | [[(2~{R},3~{R},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 5 |
| POP | PYROPHOSPHATE 2- | 5 |
| UPU | [(2R,3S,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]METHYL (2R,3S,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-HYDROXY-2-(HYDROXYMETHYL)TETRAHYDROFURAN-3-YL HYDROGEN (S)-PHOSPHATE | 5 |
| YP8 | (8S)-5-benzyl-2-({[(5P)-2-chloro-5-(1-methyl-1H-pyrazol-3-yl)phenyl]methyl}amino)[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one | 5 |
| AEV | 2-(4,5-dichloro-1H-benzimidazol-2-yl)-5-methyl-4-[(1R)-3-oxo-1,3-dihydro-2-benzofuran-1-yl]-1,2-dihydro-3H-pyrazol-3-one | 4 |